DVAX Competitors & Alternatives
Compare Dynavax Technologies Corporation with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
DVAX
Main Stock$15.50
Tradestie Score
48
Market Cap
$1.21B
Revenue Growth
0.2%
Analyst Upside
+41.9%
Top Competitors
46 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANIP
ANI Pharmaceuticals, Inc.
|
$72.18
|
$2.01B | 15.9 | 40 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$28.64
|
$1.90B | 21.5 | 42 | Compare |
|
TLRY
Tilray Brands, Inc. Common Stock
|
$3.61
|
$1.84B | - | 49 | Compare |
|
HROW
Harrow, Inc. Common Stock
|
$30.48
|
$1.79B | - | 46 | Compare |
|
PAHC
Phibro Animal Health Corporation Class A
|
$37.24
|
$1.65B | 14.7 | 44 | Compare |
|
BCRX
BioCryst Pharmaceuticals Inc
|
$8.17
|
$1.55B | - | 47 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$27.79
|
$1.49B | - | 54 | Compare |
|
AVDL
Avadel Pharmaceuticals plc Ordinary Share
|
$21.64
|
$1.46B | - | 48 | Compare |
|
EVO
Evotec SE American Depositary Shares
|
$1.60
|
$1.34B | - | 55 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$9.08
|
$1.29B | - | 43 | Compare |
More DVAX Analysis
Data updated: Oct 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
46 stocks in this industry